{"entity":{"type":"insider","cik":"0001348587","url":"/insider/0001348587","json_url":"/insider/0001348587.json","name":"Allen Patricia L","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":63,"n_filings":7,"first":"2007-10-26","last":"2026-02-13","span_basis":"filed_date"},"name_variants":[{"name":"Allen Patricia L","source":"filing","n_filings":7,"first_seen":"2007-10-26","last_seen":"2026-02-13"}],"transactions":[{"id":6056509,"accession":"0001104659-26-015342","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-26-015342","line_url":"/filing/0001104659-26-015342#line-4","is_derivative":false,"issuer_cik":"0001348587","issuer_name":"Zenas BioPharma, Inc.","issuer_ticker":"ZBIO","issuer_name_source":null,"issuer_url":"/issuer/0001348587","owner_cik":"0001348587","owner_name":"Allen Patricia L","owner_display_name":"Allen Patricia L","owner_url":"/insider/0001348587","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4160.0,"shares_display":"4,160","price_per_share":26.36,"price_display":"26.36","price_state":"stated","total_value":109657.6,"total_display":"109,657.60","total_whole":"109,658","shares_owned_after":19860.0,"shares_owned_after_display":"19,860","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-13","filed_date":"2026-02-13","scope":"insider"},{"id":6056506,"accession":"0001104659-26-015342","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-26-015342","line_url":"/filing/0001104659-26-015342","is_derivative":false,"issuer_cik":"0001348587","issuer_name":"Zenas BioPharma, Inc.","issuer_ticker":"ZBIO","issuer_name_source":null,"issuer_url":"/issuer/0001348587","owner_cik":"0001348587","owner_name":"Allen Patricia L","owner_display_name":"Allen Patricia L","owner_url":"/insider/0001348587","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15700.0,"shares_display":"15,700","price_per_share":24.846369426751593,"price_display":"24.85","price_state":"stated","total_value":390088.0,"total_display":"390,088.00","total_whole":"390,088","shares_owned_after":10700.0,"shares_owned_after_display":"10,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-12","filed_date":"2026-02-13","scope":"insider","n_lines":3},{"id":2899238,"accession":"0001209191-20-034676","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-034676","line_url":"/filing/0001209191-20-034676#line-4","is_derivative":false,"issuer_cik":"0001348587","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001348587","owner_cik":"0001348587","owner_name":"Allen Patricia L","owner_display_name":"Allen Patricia L","owner_url":"/insider/0001348587","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5635.0,"shares_display":"5,635","price_per_share":55.9004,"price_display":"55.90","price_state":"stated","total_value":314998.754,"total_display":"314,998.75","total_whole":"314,999","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-05","filed_date":"2020-06-05","scope":"insider"},{"id":2899224,"accession":"0001209191-20-034676","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-034676","line_url":"/filing/0001209191-20-034676#line-2","is_derivative":false,"issuer_cik":"0001348587","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001348587","owner_cik":"0001348587","owner_name":"Allen Patricia L","owner_display_name":"Allen Patricia L","owner_url":"/insider/0001348587","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6365.0,"shares_display":"6,365","price_per_share":59.1437,"price_display":"59.14","price_state":"stated","total_value":376449.6505,"total_display":"376,449.65","total_whole":"376,450","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-03","filed_date":"2020-06-05","scope":"insider"},{"id":2224226,"accession":"0001209191-20-005130","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-005130","line_url":"/filing/0001209191-20-005130","is_derivative":false,"issuer_cik":"0001348587","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001348587","owner_cik":"0001348587","owner_name":"Allen Patricia L","owner_display_name":"Allen Patricia L","owner_url":"/insider/0001348587","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":66.133004224,"price_display":"66.13","price_state":"stated","total_value":1653325.1056,"total_display":"1,653,325.11","total_whole":"1,653,325","shares_owned_after":7196.0,"shares_owned_after_display":"7,196","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-24","filed_date":"2020-01-28","scope":"insider","n_lines":3},{"id":2446876,"accession":"0000899243-16-025724","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-16-025724","line_url":"/filing/0000899243-16-025724#line-2","is_derivative":false,"issuer_cik":"0001348587","issuer_name":"ZAFGEN, INC.","issuer_ticker":"ZFGN","issuer_name_source":null,"issuer_url":"/issuer/0001348587","owner_cik":"0001348587","owner_name":"Allen Patricia L","owner_display_name":"Allen Patricia L","owner_url":"/insider/0001348587","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8200.0,"shares_display":"8,200","price_per_share":3.15,"price_display":"3.15","price_state":"stated","total_value":25830.0,"total_display":"25,830.00","total_whole":"25,830","shares_owned_after":19793.0,"shares_owned_after_display":"19,793","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-26","filed_date":"2016-07-26","scope":"insider"},{"id":2446872,"accession":"0000899243-16-025724","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-16-025724","line_url":"/filing/0000899243-16-025724#line-1","is_derivative":false,"issuer_cik":"0001348587","issuer_name":"ZAFGEN, INC.","issuer_ticker":"ZFGN","issuer_name_source":null,"issuer_url":"/issuer/0001348587","owner_cik":"0001348587","owner_name":"Allen Patricia L","owner_display_name":"Allen Patricia L","owner_url":"/insider/0001348587","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7800.0,"shares_display":"7,800","price_per_share":3.081,"price_display":"3.08","price_state":"stated","total_value":24031.8,"total_display":"24,031.80","total_whole":"24,032","shares_owned_after":11593.0,"shares_owned_after_display":"11,593","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-25","filed_date":"2016-07-26","scope":"insider"},{"id":5790291,"accession":"0001325812-09-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001325812-09-000004","line_url":"/filing/0001325812-09-000004#line-2","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001348587","owner_name":"Allen Patricia L","owner_display_name":"Allen Patricia L","owner_url":"/insider/0001348587","role":"Officer (VP of Finance/Treasurer)","role_mark":"O","role_mark_label":"Officer (VP of Finance/Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Finance/Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":17.6298,"price_display":"17.63","price_state":"stated","total_value":440745.0,"total_display":"440,745.00","total_whole":"440,745","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-04-22","filed_date":"2009-04-24","scope":"insider"},{"id":7576804,"accession":"0001325812-07-000040","txn_seq":22,"anchor":"line-22","filing_url":"/filing/0001325812-07-000040","line_url":"/filing/0001325812-07-000040","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001348587","owner_name":"Allen Patricia L","owner_display_name":"Allen Patricia L","owner_url":"/insider/0001348587","role":"Officer (VP of Finance/Treasurer)","role_mark":"O","role_mark_label":"Officer (VP of Finance/Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Finance/Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6190.0,"shares_display":"6,190","price_per_share":32.171458804523425,"price_display":"32.17","price_state":"stated","total_value":199141.33,"total_display":"199,141.33","total_whole":"199,141","shares_owned_after":5660.0,"shares_owned_after_display":"5,660","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-10-25","filed_date":"2007-10-26","scope":"insider","n_lines":22},{"id":7317981,"accession":"0001325812-07-000039","txn_seq":30,"anchor":"line-30","filing_url":"/filing/0001325812-07-000039","line_url":"/filing/0001325812-07-000039#line-30","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001348587","owner_name":"Allen Patricia L","owner_display_name":"Allen Patricia L","owner_url":"/insider/0001348587","role":"Officer (VP of Finance/Treasurer)","role_mark":"O","role_mark_label":"Officer (VP of Finance/Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Finance/Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1900.0,"shares_display":"1,900","price_per_share":31.89,"price_display":"31.89","price_state":"stated","total_value":60591.0,"total_display":"60,591.00","total_whole":"60,591","shares_owned_after":11855.0,"shares_owned_after_display":"11,855","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-10-25","filed_date":"2007-10-26","scope":"insider"},{"id":7317979,"accession":"0001325812-07-000039","txn_seq":29,"anchor":"line-29","filing_url":"/filing/0001325812-07-000039","line_url":"/filing/0001325812-07-000039#line-29","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001348587","owner_name":"Allen Patricia L","owner_display_name":"Allen Patricia L","owner_url":"/insider/0001348587","role":"Officer (VP of Finance/Treasurer)","role_mark":"O","role_mark_label":"Officer (VP of Finance/Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Finance/Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1900.0,"shares_display":"1,900","price_per_share":31.88,"price_display":"31.88","price_state":"stated","total_value":60572.0,"total_display":"60,572.00","total_whole":"60,572","shares_owned_after":13755.0,"shares_owned_after_display":"13,755","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-10-25","filed_date":"2007-10-26","scope":"insider"},{"id":7317977,"accession":"0001325812-07-000039","txn_seq":28,"anchor":"line-28","filing_url":"/filing/0001325812-07-000039","line_url":"/filing/0001325812-07-000039#line-28","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001348587","owner_name":"Allen Patricia L","owner_display_name":"Allen Patricia L","owner_url":"/insider/0001348587","role":"Officer (VP of Finance/Treasurer)","role_mark":"O","role_mark_label":"Officer (VP of Finance/Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Finance/Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1800.0,"shares_display":"1,800","price_per_share":31.93,"price_display":"31.93","price_state":"stated","total_value":57474.0,"total_display":"57,474.00","total_whole":"57,474","shares_owned_after":9855.0,"shares_owned_after_display":"9,855","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-10-25","filed_date":"2007-10-26","scope":"insider"},{"id":7317975,"accession":"0001325812-07-000039","txn_seq":27,"anchor":"line-27","filing_url":"/filing/0001325812-07-000039","line_url":"/filing/0001325812-07-000039#line-27","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001348587","owner_name":"Allen Patricia L","owner_display_name":"Allen Patricia L","owner_url":"/insider/0001348587","role":"Officer (VP of Finance/Treasurer)","role_mark":"O","role_mark_label":"Officer (VP of Finance/Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Finance/Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1200.0,"shares_display":"1,200","price_per_share":31.7,"price_display":"31.70","price_state":"stated","total_value":38040.0,"total_display":"38,040.00","total_whole":"38,040","shares_owned_after":18470.0,"shares_owned_after_display":"18,470","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-10-25","filed_date":"2007-10-26","scope":"insider"},{"id":7317974,"accession":"0001325812-07-000039","txn_seq":26,"anchor":"line-26","filing_url":"/filing/0001325812-07-000039","line_url":"/filing/0001325812-07-000039#line-26","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001348587","owner_name":"Allen Patricia L","owner_display_name":"Allen Patricia L","owner_url":"/insider/0001348587","role":"Officer (VP of Finance/Treasurer)","role_mark":"O","role_mark_label":"Officer (VP of Finance/Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Finance/Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":787.0,"shares_display":"787","price_per_share":31.87,"price_display":"31.87","price_state":"stated","total_value":25081.69,"total_display":"25,081.69","total_whole":"25,082","shares_owned_after":15655.0,"shares_owned_after_display":"15,655","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-10-25","filed_date":"2007-10-26","scope":"insider"},{"id":7317972,"accession":"0001325812-07-000039","txn_seq":25,"anchor":"line-25","filing_url":"/filing/0001325812-07-000039","line_url":"/filing/0001325812-07-000039#line-25","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001348587","owner_name":"Allen Patricia L","owner_display_name":"Allen Patricia L","owner_url":"/insider/0001348587","role":"Officer (VP of Finance/Treasurer)","role_mark":"O","role_mark_label":"Officer (VP of Finance/Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Finance/Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":31.78,"price_display":"31.78","price_state":"stated","total_value":22246.0,"total_display":"22,246.00","total_whole":"22,246","shares_owned_after":17170.0,"shares_owned_after_display":"17,170","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-10-25","filed_date":"2007-10-26","scope":"insider"},{"id":7317970,"accession":"0001325812-07-000039","txn_seq":24,"anchor":"line-24","filing_url":"/filing/0001325812-07-000039","line_url":"/filing/0001325812-07-000039#line-24","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001348587","owner_name":"Allen Patricia L","owner_display_name":"Allen Patricia L","owner_url":"/insider/0001348587","role":"Officer (VP of Finance/Treasurer)","role_mark":"O","role_mark_label":"Officer (VP of Finance/Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Finance/Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":31.69,"price_display":"31.69","price_state":"stated","total_value":22183.0,"total_display":"22,183.00","total_whole":"22,183","shares_owned_after":19670.0,"shares_owned_after_display":"19,670","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-10-25","filed_date":"2007-10-26","scope":"insider"},{"id":7317968,"accession":"0001325812-07-000039","txn_seq":23,"anchor":"line-23","filing_url":"/filing/0001325812-07-000039","line_url":"/filing/0001325812-07-000039#line-23","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001348587","owner_name":"Allen Patricia L","owner_display_name":"Allen Patricia L","owner_url":"/insider/0001348587","role":"Officer (VP of Finance/Treasurer)","role_mark":"O","role_mark_label":"Officer (VP of Finance/Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Finance/Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":31.97,"price_display":"31.97","price_state":"stated","total_value":19182.0,"total_display":"19,182.00","total_whole":"19,182","shares_owned_after":9055.0,"shares_owned_after_display":"9,055","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-10-25","filed_date":"2007-10-26","scope":"insider"},{"id":7317964,"accession":"0001325812-07-000039","txn_seq":22,"anchor":"line-22","filing_url":"/filing/0001325812-07-000039","line_url":"/filing/0001325812-07-000039#line-22","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001348587","owner_name":"Allen Patricia L","owner_display_name":"Allen Patricia L","owner_url":"/insider/0001348587","role":"Officer (VP of Finance/Treasurer)","role_mark":"O","role_mark_label":"Officer (VP of Finance/Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Finance/Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":528.0,"shares_display":"528","price_per_share":31.86,"price_display":"31.86","price_state":"stated","total_value":16822.08,"total_display":"16,822.08","total_whole":"16,822","shares_owned_after":16442.0,"shares_owned_after_display":"16,442","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-10-25","filed_date":"2007-10-26","scope":"insider"},{"id":7317962,"accession":"0001325812-07-000039","txn_seq":21,"anchor":"line-21","filing_url":"/filing/0001325812-07-000039","line_url":"/filing/0001325812-07-000039#line-21","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001348587","owner_name":"Allen Patricia L","owner_display_name":"Allen Patricia L","owner_url":"/insider/0001348587","role":"Officer (VP of Finance/Treasurer)","role_mark":"O","role_mark_label":"Officer (VP of Finance/Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Finance/Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":32.04,"price_display":"32.04","price_state":"stated","total_value":16020.0,"total_display":"16,020.00","total_whole":"16,020","shares_owned_after":7655.0,"shares_owned_after_display":"7,655","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-10-25","filed_date":"2007-10-26","scope":"insider"},{"id":7317961,"accession":"0001325812-07-000039","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001325812-07-000039","line_url":"/filing/0001325812-07-000039#line-20","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001348587","owner_name":"Allen Patricia L","owner_display_name":"Allen Patricia L","owner_url":"/insider/0001348587","role":"Officer (VP of Finance/Treasurer)","role_mark":"O","role_mark_label":"Officer (VP of Finance/Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Finance/Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":31.74,"price_display":"31.74","price_state":"stated","total_value":12696.0,"total_display":"12,696.00","total_whole":"12,696","shares_owned_after":17870.0,"shares_owned_after_display":"17,870","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-10-25","filed_date":"2007-10-26","scope":"insider"},{"id":7317959,"accession":"0001325812-07-000039","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0001325812-07-000039","line_url":"/filing/0001325812-07-000039#line-19","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001348587","owner_name":"Allen Patricia L","owner_display_name":"Allen Patricia L","owner_url":"/insider/0001348587","role":"Officer (VP of Finance/Treasurer)","role_mark":"O","role_mark_label":"Officer (VP of Finance/Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Finance/Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":395.0,"shares_display":"395","price_per_share":32.05,"price_display":"32.05","price_state":"stated","total_value":12659.75,"total_display":"12,659.75","total_whole":"12,660","shares_owned_after":7260.0,"shares_owned_after_display":"7,260","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-10-25","filed_date":"2007-10-26","scope":"insider"},{"id":7317957,"accession":"0001325812-07-000039","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001325812-07-000039","line_url":"/filing/0001325812-07-000039#line-18","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001348587","owner_name":"Allen Patricia L","owner_display_name":"Allen Patricia L","owner_url":"/insider/0001348587","role":"Officer (VP of Finance/Treasurer)","role_mark":"O","role_mark_label":"Officer (VP of Finance/Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Finance/Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":31.98,"price_display":"31.98","price_state":"stated","total_value":9594.0,"total_display":"9,594.00","total_whole":"9,594","shares_owned_after":8755.0,"shares_owned_after_display":"8,755","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-10-25","filed_date":"2007-10-26","scope":"insider"},{"id":7317956,"accession":"0001325812-07-000039","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001325812-07-000039","line_url":"/filing/0001325812-07-000039#line-17","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001348587","owner_name":"Allen Patricia L","owner_display_name":"Allen Patricia L","owner_url":"/insider/0001348587","role":"Officer (VP of Finance/Treasurer)","role_mark":"O","role_mark_label":"Officer (VP of Finance/Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Finance/Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":32.02,"price_display":"32.02","price_state":"stated","total_value":6404.0,"total_display":"6,404.00","total_whole":"6,404","shares_owned_after":8255.0,"shares_owned_after_display":"8,255","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-10-25","filed_date":"2007-10-26","scope":"insider"},{"id":7317954,"accession":"0001325812-07-000039","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001325812-07-000039","line_url":"/filing/0001325812-07-000039#line-16","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001348587","owner_name":"Allen Patricia L","owner_display_name":"Allen Patricia L","owner_url":"/insider/0001348587","role":"Officer (VP of Finance/Treasurer)","role_mark":"O","role_mark_label":"Officer (VP of Finance/Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Finance/Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":31.99,"price_display":"31.99","price_state":"stated","total_value":6398.0,"total_display":"6,398.00","total_whole":"6,398","shares_owned_after":8555.0,"shares_owned_after_display":"8,555","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-10-25","filed_date":"2007-10-26","scope":"insider"},{"id":7317952,"accession":"0001325812-07-000039","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001325812-07-000039","line_url":"/filing/0001325812-07-000039#line-15","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001348587","owner_name":"Allen Patricia L","owner_display_name":"Allen Patricia L","owner_url":"/insider/0001348587","role":"Officer (VP of Finance/Treasurer)","role_mark":"O","role_mark_label":"Officer (VP of Finance/Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Finance/Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":31.92,"price_display":"31.92","price_state":"stated","total_value":6384.0,"total_display":"6,384.00","total_whole":"6,384","shares_owned_after":11655.0,"shares_owned_after_display":"11,655","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-10-25","filed_date":"2007-10-26","scope":"insider"}],"collapsed":true,"next_cursor":"2007-10-25|7317952","ledger_fault":false,"count":{"value":63,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":57,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":63},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001953926","name":"Zenas BioPharma, Inc.","url":"/issuer/0001953926","role":"Director","n_filings":1,"first_seen":"2026-02-13","last_seen":"2026-02-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001654151","name":"Deciphera Pharmaceuticals, Inc.","url":"/issuer/0001654151","role":"Director","n_filings":2,"first_seen":"2020-01-28","last_seen":"2020-06-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001374690","name":"ZAFGEN, INC.","url":"/issuer/0001374690","role":"Officer (Chief Financial Officer)","n_filings":1,"first_seen":"2016-07-26","last_seen":"2016-07-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001178670","name":"ALNYLAM PHARMACEUTICALS, INC.","url":"/issuer/0001178670","role":"Officer (VP of Finance/Treasurer)","n_filings":3,"first_seen":"2007-10-26","last_seen":"2009-04-24"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001348587","retrieved_at":"2026-08-26T10:27:06+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}